[Current trends of NASH/NAFLD in Asia-Pacific region].
In Japan, much attention has been paid to NASH and NAFLD for the past several years and the prevalence of this disease entity has been estimated, and NASH is thought to be present in 10% of those who have fatty liver diseases. Other points out the prevalence of NASH in Japan as 6 to 8 hundred thousand patients. The last two or three decades have seen the evolution of Western-style life of near complete inactivity, energy-dense food choices and liberal fiscal resources to obtain them and other means to avoid physical activity. Moreover, what is increasingly apparent is that NASH and NAFLD is not a Western disease and many population groups in the Asia-Pacific region are particularly prone to type 2 diabetes. Thus, it is not surprising that NASH has increasingly been diagnosed in several regions in Asia including Indonesia, Malaysia, Philippines, Thailand and India.
Ishii
Hiromasa
H
Division of Gastroenterology, Department of Internal Medicine, School of Medicine, Keio University.
D001208:Asia / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000209:etiology; D005234:Fatty Liver / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D005247:Feeding Behavior; D006801:Humans; D008019:Life Style; D009765:Obesity / Q000453:epidemiology / Q000209:etiology; D010139:Pacific Islands / Q000453:epidemiology; D015995:Prevalence